Strategic Blueprint, LLC Pfizer Inc Transaction History

Strategic Blueprint, LLC

$1.54 Billion
Q4 2024

A detailed history of Strategic Blueprint, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Strategic Blueprint, LLC holds 47,169 shares of PFE stock, worth $1.26 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

47,169

Previous 46,227 2.04%

Holding current value

$1.26 Million

Previous $1.34 Million 6.43%

% of portfolio

0.08%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$24.8 - $30.19 $23,361 - $28,438	942 Added 2.04%	47,169 $1.25 Million
Q3 2024 Oct 25, 2024	SELL	$27.7 - $31.39 $170,687 - $193,425	-6,162 Reduced 11.76%	46,227 $1.34 Million
Q2 2024 Jul 26, 2024	BUY	$25.26 - $29.6 $43,320 - $50,764	1,715 Added 3.38%	52,389 $1.47 Million
Q1 2024 Apr 23, 2024	BUY	$25.89 - $29.73 $384,854 - $441,936	14,865 Added 41.51%	50,674 $1.41 Million
Q4 2023 Jan 25, 2024	SELL	$26.13 - $33.94 $249,698 - $324,330	-9,556 Reduced 21.06%	35,809 $1.03 Million
Q3 2023 Oct 18, 2023	BUY	$32.09 - $37.51 $33,469 - $39,122	1,043 Added 2.35%	45,365 $1.5 Million
Q2 2023 Oct 18, 2023	BUY	$36.12 - $41.79 $61,945 - $71,669	1,715 Added 4.03%	44,322 $1.63 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $1.77 Million - $2.31 Million	-45,042 Reduced 51.39%	42,607 $1.74 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $2.12 Million - $2.77 Million	50,855 Added 138.22%	87,649 $0
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $108,874 - $132,908	2,488 Added 7.25%	36,794 $1.61 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $79,938 - $94,782	1,718 Added 5.27%	34,306 $1.8 Million
Q1 2022 Aug 12, 2022	BUY	$45.75 - $56.69 $77,088 - $95,522	1,685 Added 5.45%	32,588 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $115,819 - $171,683	2,803 Added 9.98%	30,903 $1.82 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $48,473 - $62,268	1,235 Added 4.6%	28,100 $1.21 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $63,776 - $72,247	1,776 Added 7.08%	26,865 $1.05 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $27,729 - $31,273	828 Added 3.41%	25,089 $909,000
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $189,038 - $240,378	5,648 Added 30.34%	24,261 $893,000
Q3 2020 Oct 27, 2020	BUY	$31.75 - $37.25 $256,698 - $301,166	8,085 Added 76.8%	18,613 $683,000
Q2 2020 Jul 20, 2020	BUY	$30.12 - $36.54 $3,795 - $4,604	126 Added 1.21%	10,528 $344,000
Q1 2020 Apr 20, 2020	BUY	$27.03 - $38.62 $324 - $463	12 Added 0.12%	10,402 $340,000
Q4 2019 Jan 10, 2020	BUY	$32.92 - $37.36 $269,055 - $305,343	8,173 Added 368.65%	10,390 $407,000
Q3 2019 Oct 16, 2019	SELL	$32.49 - $42.13 $1.13 Million - $1.46 Million	-34,770 Reduced 94.01%	2,217 $80,000
Q2 2019 Jul 09, 2019	BUY	$36.98 - $41.52 $83,685 - $93,959	2,263 Added 6.52%	36,987 $1.6 Million
Q1 2019 Apr 10, 2019	BUY	$37.5 - $41.2 $117,412 - $128,997	3,131 Added 9.91%	34,724 $1.48 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $1.22 Million - $1.39 Million	31,593 New	31,593 $1.38 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Account

Strategic Blueprint, LLC Pfizer Inc Transaction History